(Q35091476)

6 August 2017

title

Hepatitis C and liver fibrosis (English)

1 reference

6 August 2017

1 reference

Schuppan D

1 reference

6 August 2017

Krebs A

series ordinal

1 reference

6 August 2017

Bauer M

series ordinal

1 reference

6 August 2017

Hahn EG

series ordinal

1 reference

6 August 2017

publication date

1 January 2003

1 reference

Cell Death & Differentiation

6 August 2017

published in

1 reference

6 August 2017

volume

10 Suppl 1

1 reference

6 August 2017

page(s)

S59-67

1 reference

Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c.

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

Matrix as a modulator of hepatic fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

Extracellular matrix degradation and the role of hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

Tissue inhibitors of metalloproteinases in liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

Rat liver myofibroblasts and hepatic stellate cells: different cell populations of the fibroblast lineage with fibrogenic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

Transforming growth factor beta and the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

Roles of TGF-beta in hepatic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

Host genetic factors influence disease progression in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

Hereditary hemochromatosis and alcohol: a fibrogenic cocktail

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

Excess alcohol greatly increases the prevalence of cirrhosis in hereditary hemochromatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

Liver damage in Italian patients with hereditary hemochromatosis is highly influenced by hepatitis B and C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

Cytokines in alcoholic and nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

Clinical features and natural history of nonalcoholic steatosis syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in germany: a 20-year multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

The natural course of hepatitis C virus infection after 22 years in a unique homogenous cohort: spontaneous viral clearance and chronic HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

A randomized, controlled trial of maintenance interferon therapy for patients with chronic hepatitis C virus and persistent viremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

Acute hepatitis C without and with schistosomiasis: correlation with hepatitis C-specific CD4(+) T-cell and cytokine response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

Persistent and transient replication of full-length hepatitis C virus genomes in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

Hepatitis C virus replication in mice with chimeric human livers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

Hepatitis C virus proteins: direct link to hepatic oxidative stress, steatosis, carcinogenesis and more

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

Hepatitis C virus core protein induces hepatic steatosis in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

Hepatitis C virus core protein is necessary for the maintenance of immortalized human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

Hepatitis C virus core protein enhances p53 function through augmentation of DNA binding affinity and transcriptional ability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

Hepatitis C virus core protein represses p21WAF1/Cip1/Sid1 promoter activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

Hepatitis C virus core protein inhibits apoptosis via enhanced Bcl-xL expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

Interaction of hepatitis C virus core protein with retinoid X receptor alpha modulates its transcriptional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

Expression of hepatitis C virus proteins interferes with the antiviral action of interferon independently of PKR-mediated control of protein synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

Modulation of cell growth by the hepatitis C virus nonstructural protein NS5A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

The role of laparoscopy in the diagnosis of cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

Blockade of type beta transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: a potential new therapy for hepatic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

Dose-dependent inhibition of hepatic fibrosis in mice by a TGF-beta soluble receptor: implications for antifibrotic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

Role and interaction of connective tissue growth factor with transforming growth factor-beta in persistent fibrosis: A mouse fibrosis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

Hepatocyte growth factor gene therapy of liver cirrhosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

Effects of Sho-saiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

Halofuginone to prevent and treat thioacetamide-induced liver fibrosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

Transforming growth factor beta1 induces the expression of alpha1(I) procollagen mRNA by a hydrogen peroxide-C/EBPbeta-dependent mechanism in rat hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

Pentoxifylline downregulates profibrogenic cytokines and procollagen I expression in rat secondary biliary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

Effect of angiotensin II type 1 receptor blockade on experimental hepatic fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

Interstitial collagens I, III, and VI sequester and modulate the multifunctional cytokine oncostatin M.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

The epithelial mitogen keratinocyte growth factor binds to collagens via the consensus sequence glycine-proline-hydroxyproline

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

Fibroblasts, myofibroblasts, and wound contraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

Soluble collagen VI induces tyrosine phosphorylation of paxillin and focal adhesion kinase and activates the MAP kinase erk2 in fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

An oral endothelin-A receptor antagonist blocks collagen synthesis and deposition in advanced rat liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

Influence of immunogenetic background on the outcome of recurrent hepatitis C after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

7 January 2021

Interferon alfa and gamma inhibit proliferation and collagen synthesis of human Ito cells in culture

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

7 January 2021

Interleukin 10: the magic bullet for liver fibrosis?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

7 January 2021

Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

7 January 2021

Antifibrotic effect of silymarin in rat secondary biliary fibrosis is mediated by downregulation of procollagen alpha1(I) and TIMP-1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

7 January 2021

Glutathione Levels Discriminate between Oxidative Stress and Transforming Growth Factor-β Signaling in Activated Rat Hepatic Stellate Cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

7 January 2021

Pentoxifylline, pentifylline, and interferons decrease type I and III procollagen mRNA levels in dermal fibroblasts: evidence for mediation by nuclear factor 1 down-regulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

7 January 2021

Collagens serve as an extracellular store of bioactive interleukin 2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

7 January 2021

Decreased PDGF receptor kinase activity in fibroblasts contracting stressed collagen matrices

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

7 January 2021

Successful Targeting to Rat Hepatic Stellate Cells Using Albumin Modified with Cyclic Peptides That Recognize the Collagen Type VI Receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401163

7 January 2021

Identifiers

DOI

10.1038/SJ.CDD.4401163

1 reference

6 August 2017

1 reference